China Pharma logo

China Pharma Share Price (NYSE: CPHI)

$1.35

-0.07

(-4.93%)

Last updated on

Check the interactive China Pharma Stock chart to analyse performance

China Pharma stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.35
    Today's High:$1.40

    Day's Volatility :3.57%

  • 52 Weeks Low:$1.20
    52 Weeks High:$3.35

    52 Weeks Volatility :64.18%

China Pharma Stock Returns

PeriodChina Pharma Holdings IncIndex (Russel 2000)
3 Months
-16.67%
0.0%
6 Months
-28.21%
0.0%
1 Year
-25.97%
0.0%
3 Years
-98.46%
-4.1%

China Pharma Holdings Inc Key Stats

Check China Pharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.42
Open
$1.36
Today's High
$1.4
Today's Low
$1.35
Market Capitalization
$4.6M
Today's Volume
$15.2K
52 Week High
$3.35
52 Week Low
$1.2
Revenue TTM
$4.4M
EBITDA
$-1.7M
Earnings Per Share (EPS)
$-1.47
Profit Margin
-83.17%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-52.72%

Stock Returns calculator for China Pharma Stock including INR - Dollar returns

The China Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

China Pharma investment value today

Current value as on today

₹76,713

Returns

₹23,287

(-23.29%)

Returns from China Pharma Stock

₹28,571 (-28.57%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards China Pharma Stock

-14%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for China Pharma Stock from India on INDmoney has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on China Pharma Stock

Rating
Trend

China Pharma Share Price Target

What analysts predicted

Upside of 122.22%

Target:

$3.00

Current:

$1.35

China Pharma share price target is $3.00, a slight Upside of 122.22% compared to current price of $1.35 as per analysts' prediction.

China Pharma Stock Insights

  • Price Movement

    In the last 1 month, CPHI stock has moved down by -18.1%
  • CPHI vs NBIX (1 yr)

    In the last 1 year, Neurocrine Biosciences Inc. has given 9.9% return, outperforming this stock by 40.6%
  • CPHI vs HLN (3 yr)

    In the last 3 years, Haleon Plc Spon Ads has given 33.4% return, outperforming this stock by 132.0%
  • Price to Sales

    ForCPHI every $1 of sales, investors are willing to pay $0.8, whereas for Neurocrine Biosciences Inc., the investors are paying $5.6 for every $1 of sales.

China Pharma Holdings Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$4.5M
↓ 35.41%
Net Income
$-4.7M
↑ 53.84%
Net Profit Margin
-104.58%
↓ 60.67%

China Pharma Technicals Summary

Sell

Neutral

Buy

China Pharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

China Pharma Holdings Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
China Pharma Holdings Inc logo
-14.63%
-28.21%
-25.97%
-98.46%
-99.23%
Haleon Plc Spon Ads logo
1.5%
-7.33%
-3.49%
69.05%
32.32%
United Therapeutics Corporation logo
3.57%
-1.69%
-13.51%
34.83%
71.41%
Zoetis Inc. logo
6.13%
-8.28%
-14.8%
-1.88%
-3.48%
Neurocrine Biosciences Inc. logo
8.29%
21.94%
11.59%
32.16%
20.59%

About China Pharma Holdings Inc

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection for edema diseases, hypertension, acute renal failure, hyperkalemia, hypercalcemia, and acute drug poisoning; and Candesartan for hypertension. It offers Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and Pseudophedrine Hydrochlorida sustained release tablets. It offers Hepatocyte growth-promoting factors, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection for nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It supplies its products to hospitals and OTC pharmacies through provincial and municipal pharmaceutical logistics companies. The company is based in Haikou, the People's Republic of China.
Organization
China Pharma
Employees
224
CEO
Ms. Zhilin Li
Industry
Health Technology

Key Management of China Pharma Holdings Inc

NameTitle
Ms. Zhilin Li
President, CEO, Chairman & Interim CFO
Ms. Huang Na C.F.A.
BOD Secretary & IR Manager

Important FAQs about investing in CPHI Stock from India :

What is China Pharma share price today?

China Pharma share price today is $1.35 as on at the close of the market. China Pharma share today touched a day high of $1.40 and a low of $1.35.

What is the 52 week high and 52 week low for China Pharma share?

China Pharma share touched a 52 week high of $3.35 and a 52 week low of $1.20. China Pharma stock price today i.e. is closed at $1.35, lower by 59.7% versus the 52 week high.

How to invest in China Pharma Stock (CPHI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for China Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in China Pharma Shares that will get you 1.1111 shares as per China Pharma share price of $1.35 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy China Pharma Stock (CPHI) from India?

Indian investors can start investing in China Pharma (CPHI) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in China Pharma stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on China Pharma share’s latest price of $1.35 as on August 30, 2025 at 1:29 am IST, you will get 7.4074 shares of China Pharma. Learn more about fractional shares .

What are the returns that China Pharma has given to Indian investors in the last 5 years?

China Pharma stock has given -99.23% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?